logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12734139 B1

PDFFull Text
Date of Patent:
Sep. 15, 2026

Filed:

Jan. 26, 2024

Ensifentrine for decreasing the frequency/severity of copd exacerbations

Applicant:

Verona Pharma Limited, London, GB;

Inventors:

Tara Renae Rheault, Cary, NC (US);

Kathleen Rickard, Durham, NC (US);

Thomas Bengtsson, Lund, SE;

Assignee:

Verona Pharma Limited, London, GB;

Attorney:

Foley & Lardner LLP

Primary Examiner:

Sarah Pihonak

Assistant Examiner:

Padmaja S Rao

Int. Cl.
CPC ...
A61K 31/137 (2006.01); A61K 9/00 (2006.01); A61K 9/10 (2006.01); A61K 31/519 (2006.01); A61K 31/573 (2006.01); A61K 45/06 (2006.01); A61K 47/02 (2006.01); A61K 47/26 (2006.01); A61P 11/00 (2006.01); A61P 11/08 (2006.01);
U.S. Cl.
CPC ...
A61K 31/137 (2013.01); A61K 9/0078 (2013.01); A61K 9/10 (2013.01); A61K 31/519 (2013.01); A61K 31/573 (2013.01); A61K 45/06 (2013.01); A61K 47/02 (2013.01); A61K 47/26 (2013.01); A61P 11/00 (2018.01); A61P 11/08 (2018.01);
Abstract

The present invention relates to a compound for use in a method for decreasing the frequency and/or severity of chronic obstructive pulmonary disease (COPD) exacerbations in a patient suffering from COPD, wherein the compound is ensifentrine or a pharmaceutically acceptable salt thereof. The present invention also relates to a compound for use in a method for treating chronic obstructive pulmonary disease (COPD) in a patient, wherein: the compound is ensifentrine or a pharmaceutically acceptable salt thereof; and the patient is susceptible to COPD exacerbations.

Find Patent Forward Citations

Rheault, Tara. (2026). Ensifentrine for decreasing the frequency/severity of copd exacerbations (U.S. Patent No. 12734139). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12734139

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…